Rua Bioscience Shareholder Newsletter March 2022

Today Rua Bioscience (NZX: RUA) released its Shareholder Newsletter. As well as being a recap of Rua's top stories, you'll find other information that will give you insight into the industry, the broader market, and the way Rua conducts itself as a company committed to creating cannabinoid-based medicines that change people's lives. In this issue: - The Zalm acquisition - Medsafe's approval of our first product - The merging of two kaupapa: Rua and E3C's landmark grower partnership - Farm to pharmacy innovation - Umanga, our upcoming careers series We also introduce you to some of our team. For further information, please contact: Kerry Donovan Rua Bioscience Communications Manager kerry.donovan@ruabio.com End CA:00388370 For:RUA Type:GENERAL Time:2022-03-04 12:00:08